Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
78.51 USD | -0.87% | +1.46% | -10.37% |
Aug. 15 | The latest transactions by star managers | |
Aug. 05 | JPMorgan Adjusts Price Target on CoStar to $108 From $102 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.4B | 1.66B | 1.94B | 2.18B | 2.46B | |||||
Total Revenues | 1.4B | 1.66B | 1.94B | 2.18B | 2.46B | |||||
Cost of Goods Sold, Total | 289M | 309M | 357M | 414M | 492M | |||||
Gross Profit | 1.11B | 1.35B | 1.59B | 1.77B | 1.96B | |||||
Selling General & Admin Expenses, Total | 592M | 841M | 886M | 1.03B | 1.38B | |||||
R&D Expenses | 121M | 157M | 194M | 214M | 261M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 34M | 62.46M | 74.82M | 73.56M | 42.2M | |||||
Other Operating Expenses, Total | 747M | 1.06B | 1.15B | 1.32B | 1.68B | |||||
Operating Income | 364M | 289M | 432M | 451M | 282M | |||||
Interest Expense, Total | -2.62M | -21.79M | -32.32M | -32.32M | -31.4M | |||||
Interest And Investment Income | 19.02M | 4.4M | 695K | 64.45M | 245M | |||||
Net Interest Expenses | 16.4M | -17.4M | -31.62M | 32.12M | 214M | |||||
Currency Exchange Gains (Loss) | - | -200K | 300K | 1.4M | 3M | |||||
Other Non Operating Income (Expenses) | - | -86K | 2.95M | 1.98M | 2.4M | |||||
EBT, Excl. Unusual Items | 380M | 272M | 404M | 486M | 501M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | -541K | - | - | - | |||||
Asset Writedown | - | - | - | -9K | - | |||||
Legal Settlements | 11M | - | - | - | - | |||||
Other Unusual Items | - | - | - | -4K | - | |||||
EBT, Incl. Unusual Items | 391M | 271M | 404M | 486M | 501M | |||||
Income Tax Expense | 75.99M | 43.85M | 111M | 117M | 127M | |||||
Earnings From Continuing Operations | 315M | 227M | 293M | 369M | 375M | |||||
Net Income to Company | 315M | 227M | 293M | 369M | 375M | |||||
Net Income - (IS) | 315M | 227M | 293M | 369M | 375M | |||||
Net Income to Common Incl Extra Items | 315M | 227M | 293M | 369M | 375M | |||||
Net Income to Common Excl. Extra Items | 315M | 227M | 293M | 369M | 375M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.87 | 0.6 | 0.75 | 0.93 | 0.92 | |||||
Basic EPS - Continuing Operations | 0.87 | 0.6 | 0.75 | 0.93 | 0.92 | |||||
Basic Weighted Average Shares Outstanding | 363M | 381M | 392M | 396M | 405M | |||||
Net EPS - Diluted | 0.86 | 0.59 | 0.74 | 0.93 | 0.92 | |||||
Diluted EPS - Continuing Operations | 0.86 | 0.59 | 0.74 | 0.93 | 0.92 | |||||
Diluted Weighted Average Shares Outstanding | 366M | 383M | 394M | 398M | 407M | |||||
Normalized Basic EPS | 0.65 | 0.45 | 0.64 | 0.77 | 0.77 | |||||
Normalized Diluted EPS | 0.65 | 0.44 | 0.64 | 0.76 | 0.77 | |||||
American Depositary Receipts Ratio (ADR) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Supplemental Items | ||||||||||
EBITDA | 445M | 406M | 572M | 589M | 390M | |||||
EBITA | 419M | 377M | 536M | 554M | 356M | |||||
EBIT | 364M | 289M | 432M | 451M | 282M | |||||
EBITDAR | 472M | 439M | 607M | 622M | 426M | |||||
Effective Tax Rate - (Ratio) | 19.44 | 16.18 | 27.58 | 24.05 | 25.25 | |||||
Current Domestic Taxes | 66.46M | 55.19M | 85.91M | 148M | 163M | |||||
Current Foreign Taxes | 1.3M | 195K | 1.33M | 664K | 900K | |||||
Total Current Taxes | 67.77M | 55.38M | 87.24M | 148M | 164M | |||||
Deferred Domestic Taxes | 9.3M | -10.52M | 31.33M | -30.04M | -34.6M | |||||
Deferred Foreign Taxes | -1.08M | -1M | -7.16M | -1.17M | -2.6M | |||||
Total Deferred Taxes | 8.22M | -11.53M | 24.16M | -31.2M | -37.2M | |||||
Normalized Net Income | 237M | 170M | 252M | 304M | 313M | |||||
Interest on Long-Term Debt | 3M | 21.79M | 32.32M | 32.32M | 31.4M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 164M | 270M | - | - | - | |||||
Marketing Expenses | - | - | 312M | 306M | 550M | |||||
Selling and Marketing Expenses | 400M | 525M | 610M | 672M | 974M | |||||
General and Administrative Expenses | 175M | 295M | 251M | 333M | 378M | |||||
Research And Development Expense From Footnotes | 126M | 163M | 201M | 221M | 268M | |||||
Net Rental Expense, Total | 27.59M | 32.84M | 34.88M | 33.63M | 35.7M | |||||
Imputed Operating Lease Interest Expense | - | 8.98M | 8.06M | 7.85M | 8.12M | |||||
Imputed Operating Lease Depreciation | - | 23.85M | 26.82M | 25.78M | 27.58M | |||||
Stock-Based Comp., COGS (Total) | 9.27M | - | 11.16M | 12.58M | 14.3M | |||||
Stock-Based Comp., R&D Exp. (Total) | 8.98M | - | 12.54M | 12.99M | 17.5M | |||||
Stock-Based Comp., S&M Exp. (Total) | 6.81M | - | 6.31M | 7.8M | 9.1M | |||||
Stock-Based Comp., G&A Exp. (Total) | 27.19M | - | 33.69M | 41.84M | 44.1M | |||||
Stock-Based Comp., Other (Total) | - | 54.1M | - | - | - | |||||
Total Stock-Based Compensation | 52.26M | 54.1M | 63.71M | 75.21M | 85M |